Watch Ticker

Longeveron Inc. Common Stock

Go to Longeveron Inc. Common Stock Website

$1.46

-0.18 (-10.70%)

Live

Previous Close

$1.71

Day Range

$1.608 - $1.75

Previous Day Range

$1.5501 - $1.65

Market Cap

$24.5 million USD

Day Vol.

215266

Previous Day Vol.

121103

Currency

USD

Primary Exchange

Nasdaq

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation so...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting

Longeveron presented positive long-term survival data for its Lomecel-B treatment in patients with Hypoplastic Left Heart Syndrome (HLHS). The data showed 100% 5-year survival and transplant-free rates, outperforming historical data. The findings support the potential of Lomecel-B as an adjunct therapy to improve outcomes for HLHS patients.

Related tickers: LGVN.

Read Full Article

N/A - Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference

Annovis Bio, a late-stage clinical drug platform company, announced that its Founder, President, and CEO, Maria L. Maccecchini, Ph.D., will participate in the upcoming H.C. Wainwright 26th Annual Global Investment Conference, including a company presentation and a panel discussion on non-amyloid approaches in Alzheimer's disease.

Related tickers: ANVS, AVXL, LGVN.

Read Full Article

Trending Tickers

Please sign in to view